ImmunoGen's Logo

ImmunoGen

Who We Are | ImmunoGen for Cancer Treatment using ADC Technology

Who is ImmunoGen?

IMMUNOGEN IS NOW PART OF ABBVIE Together we will be working to make a remarkable impact for cancer patients and their communities of care, raising standards of care and advancing a dynamic oncology pipeline. For 40 years, ImmunoGen has been researching and developing ADCs designed to disrupt the progression of cancer. Because we believe life deserves fewer interruptions and more good days.

This company is:

Manufacturer

Waltham, United States

501-1000 Employees

Founding year: 1981



Products & services of ImmunoGen

Product ImmunoGen Announces Proposed Public Offering of Common Stock - ImmunoGen image
Product

Verified

ImmunoGen Announces Proposed Public Offering of Common Stock - ImmunoGen

ImmunoGen Announces Proposed Public Offering of Common Stock

Product ImmunoGen Announces Proposed Public Offering of Common Stock - ImmunoGen image
Product

Verified

ImmunoGen Announces Proposed Public Offering of Common Stock - ImmunoGen

ImmunoGen Announces Proposed Public Offering of Common Stock

Product ImmunoGen Announces Pricing of Public Offering of Common Stock - ImmunoGen image
Product

Verified

ImmunoGen Announces Pricing of Public Offering of Common Stock - ImmunoGen

ImmunoGen Announces Pricing of Public Offering of Common Stock

View all products


Keywords

Manufacturing
BPDCN
Antibody-drug conjugates
Pharmaceutical preparations
Therapeutics
Ovarian cancer
Medical
Health Care
Biotechnology
Chemical Manufacturing
AML
ADCs
Heme malignancies
Pharmaceutical and Medicine Manufacturing

Industries

Science and Engineering
Others
Health Care
Manufacturing
Biotechnology

Use Cases of ImmunoGen

logo

ImmunoGen Submits Biologics License Application to the US Food and Drug Administration for Mirvetuximab Soravtansine in Ovarian Cancer - ImmunoGen

ImmunoGen Submits Biologics License Application to the US Food and Drug Administration for Mirvetuximab Soravtansine in Ovarian Cancer


Contact of ImmunoGen

City: Waltham

State: Massachusetts

Country: United States



Frequently asked questions (FAQ) about ImmunoGen

The company ImmunoGen is located in Waltham, Massachusetts, United States. It's worth noting that the company may has more corporate locations

As of the latest available information ImmunoGen has around 501-1000 employees worldwide.

ImmunoGen was founded in 1981

The company ImmunoGen has it's main focus in the industries of Science and Engineering, Others, Health Care, Manufacturing, Biotechnology

Based on the founding year and the amount of employees the company ImmunoGen seems to be a Medium-Sized Company at the current state. Note that over time that status can change

Competitors of ImmunoGen

ImmunoGenesis Logo

ImmunoGenesis

United States

11-50 Employees

2019

Agenus Logo

Agenus

United States

251-500 Employees

1994

Immunitas Therapeutics Logo

Immunitas Therapeutics

United States

11-50 Employees

2019

NantKwest Logo

NantKwest

United States

51-100 Employees

2002

Ambrx Logo

Ambrx

United States

101-250 Employees

2003

Exinda Therapeutics, LLC Logo

Exinda Therapeutics, LLC

United States

1-10 Employees

2013

Inimmune Logo

Inimmune

United States

11-50 Employees

2016

ImaginAb Logo

ImaginAb

United States

11-50 Employees

2007


Suitable topics for ImmunoGen

Topics which have been searched by others and may be interesting for you: